[正电子发射断层扫描引导下的早期预后良好型霍奇金淋巴瘤治疗：德国霍奇金淋巴瘤研究组的最终结果] - Suppr

Suppr

超能文献

[Positron emission tomography-guided treatment in early-stage favorable Hodgkin lymphoma: final results of the German Hodgkin Study Group].

作者信息

Frerker Bernd, Hildebrandt Guido

机构信息

Klinik und Poliklinik für Strahlentherapie, Universitätsmedizin Rostock, Südring 75, 18059, Rostock, Deutschland.

出版信息

Strahlenther Onkol. 2020 May;196(5):488-491. doi: 10.1007/s00066-020-01600-4.

DOI:10.1007/s00066-020-01600-4

PMID:32170351

Abstract

摘要

相似文献

[Positron emission tomography-guided treatment in early-stage favorable Hodgkin lymphoma: final results of the German Hodgkin Study Group].[正电子发射断层扫描引导下的早期预后良好型霍奇金淋巴瘤治疗：德国霍奇金淋巴瘤研究组的最终结果]

Strahlenther Onkol. 2020 May;196(5):488-491. doi: 10.1007/s00066-020-01600-4.

[Positron emission tomography-guided treatment in early-stage favorable Hodgkin lymphoma: final results of the international randomized phase III HD16 trial conducted by the German Hodgkin Study Group].[正电子发射断层扫描引导下的早期预后良好型霍奇金淋巴瘤治疗：德国霍奇金淋巴瘤研究组开展的国际随机 III 期 HD16 试验的最终结果]

Strahlenther Onkol. 2020 Apr;196(4):414-415. doi: 10.1007/s00066-020-01593-0.

[No general recommendation for waiving consolidated radiotherapy in Hodgkin lymphoma and negative PET results after completion of chemotherapy].[对于在霍奇金淋巴瘤化疗完成后PET结果为阴性时放弃巩固放疗，尚无一般性推荐意见]

Strahlenther Onkol. 2016 Aug;192(8):595-6. doi: 10.1007/s00066-016-1000-1.

Predicted Risks of Cardiovascular Disease Following Chemotherapy and Radiotherapy in the UK NCRI RAPID Trial of Positron Emission Tomography-Directed Therapy for Early-Stage Hodgkin Lymphoma.英国 NCRI RAPID 试验中，正电子发射断层扫描指导早期霍奇金淋巴瘤治疗的化疗和放疗后心血管疾病的预测风险。

J Clin Oncol. 2021 Nov 10;39(32):3591-3601. doi: 10.1200/JCO.21.00408. Epub 2021 Aug 13.

Long-Term Follow-Up of Contemporary Treatment in Early-Stage Hodgkin Lymphoma: Updated Analyses of the German Hodgkin Study Group HD7, HD8, HD10, and HD11 Trials.早期霍奇金淋巴瘤当代治疗的长期随访：德国霍奇金研究组 HD7、HD8、HD10 和 HD11 试验的更新分析。

J Clin Oncol. 2017 Jun 20;35(18):1999-2007. doi: 10.1200/JCO.2016.70.9410. Epub 2017 Apr 18.

Early-stage Hodgkin lymphoma outcomes after combined modality therapy according to the post-chemotherapy 5-point score: can residual pet-positive disease be cured with radiotherapy alone?根据化疗后5分评分评估联合治疗模式下早期霍奇金淋巴瘤的预后：单纯放疗能否治愈残留的PET阳性疾病？

Br J Haematol. 2017 Nov;179(3):488-496. doi: 10.1111/bjh.14902. Epub 2017 Aug 18.

Treatment of lymphocyte-predominant Hodgkin lymphoma.淋巴细胞为主型霍奇金淋巴瘤的治疗

Ann Oncol. 2008 Jun;19 Suppl 4:iv45-6. doi: 10.1093/annonc/mdn194.

Classical Hodgkin's lymphoma: past, present and future perspectives.

Br J Hosp Med (Lond). 2013 Nov;74(11):612-8. doi: 10.12968/hmed.2013.74.11.612.

Clinical outcome of patients with early stage favorable Hodgkin lymphoma treated with ABVD × two cycles followed by FDG-PET/CT restaging and 20 Gy of involved-site radiotherapy.早期预后良好型霍奇金淋巴瘤患者接受两个周期ABVD方案治疗，随后进行氟脱氧葡萄糖正电子发射断层扫描/计算机断层扫描（FDG-PET/CT）再分期及20 Gy受累野放疗后的临床结局。

Leuk Lymphoma. 2018 Jun;59(6):1384-1390. doi: 10.1080/10428194.2017.1376745. Epub 2017 Sep 22.

Hodgkin lymphoma: a negative interim-PET cannot circumvent the need for end-of-treatment-PET evaluation.霍奇金淋巴瘤：中期PET阴性并不能避免治疗结束时PET评估的必要性。

Br J Haematol. 2016 Nov;175(4):652-660. doi: 10.1111/bjh.14292. Epub 2016 Aug 19.

本文引用的文献

Positron Emission Tomography-Guided Treatment in Early-Stage Favorable Hodgkin Lymphoma: Final Results of the International, Randomized Phase III HD16 Trial by the German Hodgkin Study Group.正电子发射断层扫描指导早期有利型霍奇金淋巴瘤治疗：德国霍奇金研究组国际、随机 III 期 HD16 试验的最终结果。

J Clin Oncol. 2019 Nov 1;37(31):2835-2845. doi: 10.1200/JCO.19.00964. Epub 2019 Sep 10.

PET-guided treatment in patients with advanced-stage Hodgkin's lymphoma (HD18): final results of an open-label, international, randomised phase 3 trial by the German Hodgkin Study Group.PET 引导治疗晚期霍奇金淋巴瘤（HD18）：德国霍奇金研究组开展的一项开放标签、国际、随机 3 期临床试验的最终结果。

Lancet. 2017 Dec 23;390(10114):2790-2802. doi: 10.1016/S0140-6736(17)32134-7. Epub 2017 Oct 20.

Early Positron Emission Tomography Response-Adapted Treatment in Stage I and II Hodgkin Lymphoma: Final Results of the Randomized EORTC/LYSA/FIL H10 Trial.早期正电子发射断层扫描反应适应性治疗 I 期和 II 期霍奇金淋巴瘤：随机 EORTC/LYSA/FIL H10 试验的最终结果。

J Clin Oncol. 2017 Jun 1;35(16):1786-1794. doi: 10.1200/JCO.2016.68.6394. Epub 2017 Mar 14.

Results of a trial of PET-directed therapy for early-stage Hodgkin's lymphoma.早期霍奇金淋巴瘤的 PET 导向治疗试验结果。

N Engl J Med. 2015 Apr 23;372(17):1598-607. doi: 10.1056/NEJMoa1408648.

Involved Node, Site, Field and Residual Volume Radiotherapy for Lymphoma: A Comparison of Organ at Risk Dosimetry and Second Malignancy Risks.淋巴瘤累及淋巴结、部位、野及残留体积的放射治疗：危及器官剂量测定与二次恶性肿瘤风险的比较

Clin Oncol (R Coll Radiol). 2015 Jul;27(7):401-10. doi: 10.1016/j.clon.2015.03.005. Epub 2015 Apr 1.

The prognostic value of positron emission tomography performed after two courses (INTERIM-PET) of standard therapy on treatment outcome in early stage Hodgkin lymphoma: A multicentric study by the fondazione italiana linfomi (FIL).标准治疗两周期后正电子发射断层扫描（INTERIM-PET）对早期霍奇金淋巴瘤治疗结果的预后价值：意大利淋巴瘤基金会（FIL）的一项多中心研究。

Am J Hematol. 2015 Jun;90(6):499-503. doi: 10.1002/ajh.23994. Epub 2015 May 10.

Omission of dacarbazine or bleomycin, or both, from the ABVD regimen in treatment of early-stage favourable Hodgkin's lymphoma (GHSG HD13): an open-label, randomised, non-inferiority trial.ABVD 方案中省略达卡巴嗪或博来霉素或两者在治疗早期有利霍奇金淋巴瘤（GHSG HD13）中的应用：一项开放标签、随机、非劣效性试验。

Lancet. 2015 Apr 11;385(9976):1418-27. doi: 10.1016/S0140-6736(14)61469-0. Epub 2014 Dec 22.

Comparison of positron emission tomography/computed tomography with classical contrast-enhanced computed tomography in the initial staging of Hodgkin lymphoma.正电子发射断层扫描/计算机断层扫描与传统对比增强计算机断层扫描在霍奇金淋巴瘤初始分期中的比较。

Leuk Lymphoma. 2015 Feb;56(2):377-82. doi: 10.3109/10428194.2014.919635. Epub 2014 Jun 27.

Modern radiation therapy for Hodgkin lymphoma: field and dose guidelines from the international lymphoma radiation oncology group (ILROG).霍奇金淋巴瘤的现代放射治疗：国际淋巴瘤放射肿瘤学组（ILROG）的野和剂量指南。

Int J Radiat Oncol Biol Phys. 2014 Jul 15;89(4):854-62. doi: 10.1016/j.ijrobp.2013.05.005. Epub 2013 Jun 18.

Reduced-intensity chemotherapy and PET-guided radiotherapy in patients with advanced stage Hodgkin's lymphoma (HD15 trial): a randomised, open-label, phase 3 non-inferiority trial.强化化疗联合 PET 引导放疗与单纯强化化疗治疗晚期霍奇金淋巴瘤（HD15 试验）：一项随机、开放标签、III 期非劣效性试验。

Lancet. 2012 May 12;379(9828):1791-9. doi: 10.1016/S0140-6736(11)61940-5. Epub 2012 Apr 4.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验